We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

80 hedge funds and large institutions have $550M invested in GenMark Diagnostics, Inc in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more call options, than puts

Call options by funds: $92K | Put options by funds: $65K

13% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 24

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

1% more funds holding

Funds holding: 79 → 80 (+1)

5% less capital invested

Capital invested by funds: $579M → $550M (-$28.9M)

Holders
80
Holders Change
+1
Holders Change %
+1.27%
% of All Funds
2.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
27
Reduced
24
Closed
9
Calls
$92K
Puts
$65K
Net Calls
+$27K
Net Calls Change
+$26K

Top Buyers

Rank Fund Capital Flow
1
FAM
Fred Alger Management
New York
+$11.9M
2
Fidelity International
Fidelity International
Bermuda
+$3.99M
3
Deutsche Bank
Deutsche Bank
Germany
+$2.5M
4
BFA
BlackRock Fund Advisors
California
+$2.14M
5
BIT
BlackRock Institutional Trust
California
+$1.56M

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$8.78M
2
OM
Opaleye Management
Massachusetts
-$4.56M
3
Parnassus Investments
Parnassus Investments
California
-$3.67M
4
CCM
Camber Capital Management
Massachusetts
-$3.47M
5
JG
Jefferies Group
New York
-$2.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$3.1M +$259K +19,823 +9%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$2.59M -$1.39K -106 -0.1%
TCIM
28
TIAA CREF Investment Management
New York
$1.9M – – –
IGIM
29
I.G. Investment Management
Manitoba, Canada
$1.72M -$164K -12,537 -9%
Charles Schwab
30
Charles Schwab
California
$1.71M +$89.4K +6,837 +5%
BIM
31
BlackRock Investment Management
Delaware
$1.58M +$13K +995 +0.8%
CCM
32
Catapult Capital Management
New York
$1.43M – – –
AIM
33
Artemis Investment Management
United Kingdom
$1.41M – – –
Morgan Stanley
34
Morgan Stanley
New York
$1.28M +$149K +11,428 +13%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$986K -$14.4K -1,100 -1%
WMSA
36
Weiss Multi-Strategy Advisers
New York
$902K -$71.9K -5,500 -7%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$867K – – –
TA
38
Teachers Advisors
New York
$798K – – –
AllianceBernstein
39
AllianceBernstein
Tennessee
$755K – – –
Mackenzie Financial
40
Mackenzie Financial
Ontario, Canada
$744K +$98.1K +7,500 +15%
TD Asset Management
41
TD Asset Management
Ontario, Canada
$668K – – –
CS
42
Candriam SCA
Luxembourg
$584K -$131K -10,000 -18%
Swiss National Bank
43
Swiss National Bank
Switzerland
$574K – – –
Two Sigma Advisers
44
Two Sigma Advisers
New York
$557K -$204K -15,600 -27%
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$522K +$376K +28,778 +251%
ARTA
46
A.R.T. Advisors
New York
$518K +$522K +39,923 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$506K +$87.9K +6,725 +21%
SIM
48
Spark Investment Management
New York
$424K +$428K +32,700 New
CS
49
Credit Suisse
Switzerland
$422K +$169K +12,934 +66%
Wells Fargo
50
Wells Fargo
California
$411K +$284K +21,757 +219%
1
2
3 4

GNMK Hedge Fund Activity: Q1 2015 in Review

80 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q1 2015, worth a combined $550M — down 5% from $579M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new GNMK positions and 9 closed out — a net gain of 1 holder — while 27 added to existing stakes and 24 trimmed.

The largest buyer was Fred Alger Management, opening a new position worth an estimated $11.9M. The largest seller was Visium Asset Management, cutting an estimated $8.78M.

  • 80 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q1 2015, up from 79 in Q4 2014.
  • Funds reported $550M of GenMark Diagnostics, Inc stock for Q1 2015, down 5% quarter-over-quarter.
  • 10 funds opened new GenMark Diagnostics, Inc positions in Q1 2015 and 9 closed out, a net change of +1 holder.
  • The largest GenMark Diagnostics, Inc buyer in Q1 2015 was Fred Alger Management, an estimated $11.9M added.
  • The largest GenMark Diagnostics, Inc seller in Q1 2015 was Visium Asset Management, an estimated $8.78M sold.

Based on aggregated 13F filings for Q1 2015.